(VIANEWS) – AG Mortgage Investment Trust (MITT), Celsius Holdings (CELH), NVIDIA (NVDA) are the highest sales growth and return on equity stocks on this list.

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. AG Mortgage Investment Trust (MITT)

140% sales growth and 28.75% return on equity

AG Mortgage Investment Trust, Inc., a real estate investment trust, invests in a portfolio of residential mortgage-backed securities and credit investments in the United States.

AG Mortgage Investment Trust’s sales growth this year is anticipated to be 58.2% and 24.8% for next year.

Year-on-year quarterly revenue growth grew by 62.6%, now sitting on 98.48M for the twelve trailing months.

Volume

Today’s last reported volume for AG Mortgage Investment Trust is 103469 which is 44.79% below its average volume of 187434.

AG Mortgage Investment Trust’s sales growth is a negative 0% for the ongoing quarter and 140% for the next. The company’s growth estimates for the present quarter and the next is a negative 88.6% and negative -94.8%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 28.75%.

Volatility

AG Mortgage Investment Trust’s last day, last week, and last month’s current volatility was 0.65%, 1.89%, and 1.64%, respectively.

AG Mortgage Investment Trust’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.91% (day), 2.74% (last week), and 2.41% (last month), respectively.

AG Mortgage Investment Trust’s Stock Yearly Top and Bottom Value

AG Mortgage Investment Trust’s stock is valued at $12.25 at 01:22 EST, way under its 52-week high of $14.88 and way above its 52-week low of $7.53.

AG Mortgage Investment Trust’s Moving Average

AG Mortgage Investment Trust’s worth is way higher than its 50-day moving average of $10.99 and above its 200-day moving average of $11.72.

2. Celsius Holdings (CELH)

98.2% sales growth and 8.59% return on equity

Celsius Holdings, Inc. develops, markets, distributes, and sells functional calorie-burning fitness beverages in the United States and internationally.

Celsius Holdings’s sales growth this year is expected to be 98% and 54.4% for next year.

Year-on-year quarterly revenue growth grew by 116.6%, now sitting on 187.61M for the twelve trailing months.

Volume

Today’s last reported volume for Celsius Holdings is 1481720 which is 58.81% above its average volume of 932970.

Celsius Holdings’s sales growth is a negative 0% for the ongoing quarter and 98.2% for the next. The company’s growth estimates for the current quarter and the next is a negative 0% and 150%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.59%.

Volatility

Celsius Holdings’s last day, last week, and last month’s current volatility was 3.29%, 2.25%, and 2.97%, respectively.

Celsius Holdings’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 6.13% (day), 5.20% (last week), and 5.72% (last month), respectively.

Celsius Holdings’s Stock Yearly Top and Bottom Value

Celsius Holdings’s stock is valued at $88.91 at 01:22 EST, way under its 52-week high of $101.50 and way above its 52-week low of $19.80.

Celsius Holdings’s Moving Average

Celsius Holdings’s value is under its 50-day moving average of $90.17 and way above its 200-day moving average of $70.47.

3. NVIDIA (NVDA)

36.2% sales growth and 40.38% return on equity

NVIDIA Corporation operates as a visual computing company worldwide.

NVIDIA’s sales growth this year is anticipated to be 54.4% and 12.8% for next year.

Year-on-year quarterly revenue growth grew by 68.3%, now sitting on 21.9B for the twelve trailing months.

Volume

Today’s last reported volume for NVIDIA is 21694000 which is 21.98% below its average volume of 27808800.

NVIDIA’s sales growth for the next quarter is 36.2%. The company’s growth estimates for the present quarter and the next is 50.7% and 40.3%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 40.38%.

Volatility

NVIDIA’s last day, last week, and last month’s current volatility was 3.85%, 1.42%, and 2.41%, respectively.

NVIDIA’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 3.00% (day), 2.34% (last week), and 2.71% (last month), respectively.

NVIDIA’s Stock Yearly Top and Bottom Value

NVIDIA’s stock is valued at $218.62 at 01:22 EST, under its 52-week high of $230.43 and way higher than its 52-week low of $115.67.

NVIDIA’s Moving Average

NVIDIA’s value is above its 50-day moving average of $216.58 and way higher than its 200-day moving average of $184.68.

4. Myers Industries (MYE)

34.1% sales growth and 15.67% return on equity

Myers Industries, Inc. manufactures and sells polymer products for industrial, agricultural, automotive, commercial, and consumer markets in the United States and internationally.

Myers Industries’s sales growth this year is expected to be 45.6% and 5.6% for next year.

Year-on-year quarterly revenue growth grew by 58.3%, now sitting on 631.52M for the twelve trailing months.

Volume

Today’s last reported volume for Myers Industries is 55275 which is 44.99% below its average volume of 100493.

Myers Industries’s sales growth for the next quarter is 34.1%. The company’s growth estimates for the current quarter and the next is a negative 13.3% and 100%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.67%.

Volatility

Myers Industries’s last day, last week, and last month’s current volatility was 0.50%, 0.98%, and 1.45%, respectively.

Myers Industries’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.96% (day), 1.63% (last week), and 2.41% (last month), respectively.

Myers Industries’s Stock Yearly Top and Bottom Value

Myers Industries’s stock is valued at $20.30 at 01:22 EST, way below its 52-week high of $23.98 and way above its 52-week low of $13.68.

Myers Industries’s Moving Average

Myers Industries’s worth is below its 50-day moving average of $20.92 and under its 200-day moving average of $21.23.

5. Neurocrine Biosciences (NBIX)

30.2% sales growth and 34.56% return on equity

Neurocrine Biosciences, Inc., a neuroscience-focused biopharmaceutical company, discovers, develops, and delivers various treatments for people with neurological, endocrine, and psychiatric disorders.

Neurocrine Biosciences’s sales growth this year is anticipated to be 9% and 23.4% for next year.

Year-on-year quarterly revenue growth declined by 4.5%, now sitting on 1.03B for the twelve trailing months.

Volume

Today’s last reported volume for Neurocrine Biosciences is 895863 which is 44.62% above its average volume of 619444.

Neurocrine Biosciences’s sales growth for the next quarter is 30.2%. The company’s growth estimates for the current quarter and the next is 193.5% and negative -80.2%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 34.56%.

Volatility

Neurocrine Biosciences’s last day, last week, and last month’s current volatility was 1.86%, 1.05%, and 1.06%, respectively.

Neurocrine Biosciences’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 4.12% (day), 2.63% (last week), and 2.85% (last month), respectively.

Neurocrine Biosciences’s Stock Yearly Top and Bottom Value

Neurocrine Biosciences’s stock is valued at $104.54 at 01:22 EST, way below its 52-week high of $120.27 and way above its 52-week low of $84.77.

Neurocrine Biosciences’s Moving Average

Neurocrine Biosciences’s value is above its 50-day moving average of $97.74 and higher than its 200-day moving average of $95.76.

Previous days news about Neurocrine Biosciences(NBIX)

  • Neurocrine biosciences to present ongentys® (opicapone) and ingrezza® (valbenazine) data at the american neurological association 2021 virtual annual meeting. According to Business Insider on Saturday, 16 October, "A full list of all abstracts being presented by Neurocrine Biosciences at the ANA 2021 Virtual Annual Meeting are available here."

6. Raymond James Financial (RJF)

22.8% sales growth and 14.48% return on equity

Raymond James Financial, Inc., through its subsidiaries, engages in the underwriting, distribution, trading, and brokerage of equity and debt securities in the United States, Canada, and Europe.

Raymond James Financial’s sales growth this year is anticipated to be 20.3% and 9.3% for next year.

Year-on-year quarterly revenue growth grew by 25.7%, now sitting on 8.46B for the twelve trailing months.

Volume

Today’s last reported volume for Raymond James Financial is 578355 which is 26.68% below its average volume of 788833.

Raymond James Financial’s sales growth for the next quarter is 22.8%. The company’s growth estimates for the ongoing quarter and the next is 39.9% and 10.3%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.48%.

Volatility

Raymond James Financial’s last day, last week, and last month’s current volatility was 1.70%, 0.77%, and 3.71%, respectively.

Raymond James Financial’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.24% (day), 1.76% (last week), and 2.37% (last month), respectively.

Raymond James Financial’s Stock Yearly Top and Bottom Value

Raymond James Financial’s stock is valued at $100.21 at 01:22 EST, above its 52-week high of $99.72.

Raymond James Financial’s Moving Average

Raymond James Financial’s value is higher than its 50-day moving average of $92.76 and way above its 200-day moving average of $88.71.

7. First Guaranty Bancshares (FGBI)

20.6% sales growth and 11.55% return on equity

First Guaranty Bancshares, Inc. operates as the holding company for First Guaranty Bank that provides commercial banking services in Louisiana and Texas.

First Guaranty Bancshares’s sales growth this year is expected to be 15.3% and 10.2% for next year.

Year-on-year quarterly revenue growth grew by 18.8%, now sitting on 89.6M for the twelve trailing months.

Volume

Today’s last reported volume for First Guaranty Bancshares is 3968 which is 48.02% below its average volume of 7634.

First Guaranty Bancshares’s sales growth for the next quarter is 20.6%. The company’s growth estimates for the ongoing quarter and the next is 23.4% and 248.6%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.55%.

Volatility

First Guaranty Bancshares’s last day, last week, and last month’s current volatility was 0.05%, 0.55%, and 0.77%, respectively.

First Guaranty Bancshares’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 0.25% (day), 2.51% (last week), and 2.37% (last month), respectively.

First Guaranty Bancshares’s Stock Yearly Top and Bottom Value

First Guaranty Bancshares’s stock is valued at $20.45 at 01:22 EST, below its 52-week high of $22.00 and way higher than its 52-week low of $13.19.

First Guaranty Bancshares’s Moving Average

First Guaranty Bancshares’s worth is above its 50-day moving average of $19.62 and higher than its 200-day moving average of $18.99.

8. Grand Canyon Education (LOPE)

8% sales growth and 17.57% return on equity

Grand Canyon Education, Inc. provides education services to colleges and universities in the United States.

Grand Canyon Education’s sales growth this year is expected to be 7.3% and 7.3% for next year.

Year-on-year quarterly revenue growth grew by 8.5%, now sitting on 875.09M for the twelve trailing months.

Volume

Today’s last reported volume for Grand Canyon Education is 340184 which is 14.24% above its average volume of 297772.

Grand Canyon Education’s sales growth for the next quarter is 8%. The company’s growth estimates for the present quarter and the next is a negative 0.9% and 13.8%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 17.57%.

Volatility

Grand Canyon Education’s last day, last week, and last month’s current volatility was 0.14%, 1.30%, and 1.15%, respectively.

Grand Canyon Education’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.85% (day), 2.25% (last week), and 2.35% (last month), respectively.

Grand Canyon Education’s Stock Yearly Top and Bottom Value

Grand Canyon Education’s stock is valued at $89.92 at 01:22 EST, way under its 52-week high of $115.96 and way higher than its 52-week low of $75.64.

Grand Canyon Education’s Moving Average

Grand Canyon Education’s worth is above its 50-day moving average of $87.83 and below its 200-day moving average of $93.58.

LEAVE A REPLY

Please enter your comment!
Please enter your name here